G-Pen-GRGDSPCA (TFA)

G-Pen-GRGDSPCA TFA is an αvβ3-inhibiting RGD peptide. G-Pen-GRGDSPCA can limit neointimal hyperplasia and lumen stenosis after vascular injury, as well as regulate the migration and proliferation of smooth muscle cells. G-Pen-GRGDSPCA TFA can be used in the study of the mechanism of vascular injury repair[1].

12352209

Integrin

Cytoskeleton

COVID-19-immunoregulation

Others

98.76

DMSO : 100 mg/mL (ultrasonic) |H2O : ≥ 100 mg/mL

O=C1N2[C@](CCC2)([H])C(N[C@@H](CSSC(C)([C@@H](C(NCC(N[C@H](C(NCC(N[C@H](C(N[C@H]1CO)=O)CC(O)=O)=O)=O)CCCNC(N)=N)=O)=O)NC(CN)=O)C)C(N[C@@H](C)C(O)=O)=O)=O.OC(C(F)(F)F)=O.[x]

C35H57N13O14S2.xC2HF3O2

948.04 (free base)

[1]Wei-Jun Cai, et al. Activation of the integrins alpha 5beta 1 and alpha v beta 3 and focal adhesion kinase (FAK) during arteriogenesis. Mol Cell Biochem. 2009 Feb;322 (1-2) :161-9.

Blue Ice

-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

http://file.medchemexpress.com/batch_PDF/HY-P3525A/G-Pen-GRGDSPCA-TFA-SDS-MedChemExpress.pdf

Peptides

No Development Reported